Furthermore, molecular subtyping [1] supports the histological observations showing the so-called Luminal A/B and HER2-enriched cancers as those which retain a more epithelial phenotype; while the non-luminal cancers, comprising the triple negative or basal-like cancers are characterized by more mesenchymal features [1,10]. Here, ERBB2 is linked to cancer.